重症血液病患者上呼吸道病毒检测的临床意义
该研究为前瞻性队列的事后分析,纳入17个ICU的747例重症血液病患者,ICU入院时鼻拭子多重PCR检测病毒。21.3%检出病毒,检测阳性与ICU死亡相关(28.9% vs 19.3%,P=0.008);在447例急性呼吸衰竭患者中,任何呼吸道病毒检出与ICU死亡独立相关(OR 2.07,95%CI 1.22-3.50)。
要点
- 重症血液病患者上呼吸道病毒检出常见,占21.3%。
- 病毒检出与ICU死亡相关,急性呼吸衰竭者独立相关(OR 2.07)。
- 多重PCR可能有助于急性呼吸衰竭血液病患者的风险分层。
核心结论
- 重症血液病患者上呼吸道病毒检出常见,在急性呼吸衰竭患者中独立关联ICU死亡。
研究设计与样本
- 前瞻性队列的事后分析,纳入17个ICU的747例重症血液病患者,其中447例急性呼吸衰竭。
- ICU入院时采集鼻拭子冻存,用多重PCR检测病毒。
主要发现
- 21.3%患者检出病毒,56.4%为鼻病毒/肠道病毒,30.7%为流感/副流感/呼吸道合胞病毒。
- ICU死亡率26%,住院死亡率37%。
- 病毒阳性与淋巴增殖性疾病、造血干细胞移植、激素或免疫抑制剂治疗、急性呼吸衰竭(25.5% vs 16.3%,P=0.004)及ICU死亡(28.9% vs 19.3%,P=0.008)相关。
- 急性呼吸衰竭患者中,任何呼吸道病毒检出与ICU死亡独立相关(OR 2.07,95%CI 1.22-3.50)。
临床怎么用
- 对重症血液病患者,尤其急性呼吸衰竭者,可考虑上呼吸道多重PCR病毒检测以辅助风险分层。
局限性
- 为事后分析,病毒检测与结局的因果关系尚未确定,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Noninvasive diagnostic multiplex molecular tests may enable the early identification and treatment of viral infections in critically ill immunocompromised patients. OBJECTIVES: To assess the association between viral detection in nasopharyngeal swabs and ICU mortality in critically ill hematology patients. METHODS: This was a post hoc analysis of a prospective cohort of critically ill hematology patients admitted to 17 ICUs. Nasal swabs sampled and frozen at ICU admission were tested using a multiplex PCR assay. Predictors of ICU mortality and assay positivity were identified. MEASUREMENTS AND MAIN RESULTS: Of the 747 patients (447 with acute respiratory failure [ARF]), 21.3% had a virus detected (56.4% rhinovirus/enterovirus and 30.7% influenza/parainfluenza/respiratory syncytial viruses). Overall ICU and hospital mortality rates were 26% and 37%, respectively. Assay positivity was associated with lymphoproliferative disorders, hematopoietic stem cell transplantation, treatment with steroids or other immunosuppressants, ARF (25.5% vs. 16.3%; P = 0.004), and death in the ICU (28.9% vs. 19.3%; P = 0.008). The association with ICU mortality was significant for all viruses and was strongest for influenza/parainfluenza/respiratory syncytial viruses. In patients with ARF, detection of any respiratory virus was independently associated with ICU mortality (odds ratio, 2.07; 95% confidence interval, 1.22-3.50). CONCLUSIONS: Respiratory virus detection in the upper airway by multiplex PCR assay is common in critically ill hematology patients. In patients with ARF, respiratory virus detection was independently associated with ICU mortality. Multiplex PCR assay may prove helpful for the risk stratification of hematology patients with ARF. Studies to understand whether respiratory tract viruses play a causal role in outcomes are warranted.
引用
- Legoff J, Zucman N, Lemiale V, et al. Clinical Significance of Upper Airway Virus Detection in Critically Ill Hematology Patients. Am J Respir Crit Care Med. 2019. PMID: 30230909. doi:10.1164/rccm.201804-0681OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。